PPBT
Income statement / Annual
Last year (2023), Purple Biotech Ltd.'s total revenue was $0.00,
a decrease of 100.00% from the previous year.
In 2023, Purple Biotech Ltd.'s net income was -$19.88 M.
See Purple Biotech Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$0.00 |
-$910,000.00 |
-$320,000.00 |
$1.00 M |
$1.00 M |
$1.00 M |
$901,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$196,000.00
|
$201,000.00
|
$231,000.00
|
$235,000.00
|
$80.00
|
$0.00
|
$4,000.00
|
$1,999.54
|
$999.76
|
$0.00
|
| Gross Profit |
-$196,000.00
|
-$1.11 M
|
-$551,000.00
|
$765,000.00
|
$999,920.00
|
$1.00 M
|
$897,000.00
|
-$1,999.54
|
-$999.76
|
$0.00
|
| Gross Profit Ratio |
0
|
1.22
|
1.72
|
0.77
|
1
|
1
|
1
|
0
|
0
|
0
|
| Research and Development Expenses |
$17.03 M
|
$16.32 M
|
$11.83 M
|
$7.49 M
|
$2.67 M
|
$5.27 M
|
$4.64 M
|
$4.18 M
|
$2.56 M
|
$3.19 M
|
| General & Administrative Expenses |
$0.00
|
$5.96 M
|
$5.82 M
|
$6.07 M
|
$6.08 M
|
$4.45 M
|
$6.39 M
|
$3.00 M
|
$1.51 M
|
$1.27 M
|
| Selling & Marketing Expenses |
$0.00
|
$321,000.00
|
$286,000.00
|
$235,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$5.04 M
|
$6.28 M
|
$6.11 M
|
$6.31 M
|
$6.08 M
|
$4.45 M
|
$6.39 M
|
$3.00 M
|
$1.51 M
|
$1.27 M
|
| Other Expenses |
-$44.54 M
|
$0.00
|
$0.00
|
-$15.66 M
|
-$216,000.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Operating Expenses |
-$22.47 M
|
$22.60 M
|
$17.93 M
|
$13.79 M
|
$8.75 M
|
$8.83 M
|
$12.06 M
|
$7.18 M
|
$4.07 M
|
$5.18 M
|
| Cost And Expenses |
-$22.27 M
|
$22.60 M
|
$17.93 M
|
$13.79 M
|
$8.75 M
|
$8.83 M
|
$12.06 M
|
$7.18 M
|
$4.07 M
|
$5.18 M
|
| Interest Income |
$474,000.00
|
$969,000.00
|
$320,000.00
|
$254,000.00
|
$151,000.00
|
$93,000.00
|
$106,000.00
|
$138,000.00
|
$94,000.00
|
$0.00
|
| Interest Expense |
$2.18 M
|
$126,000.00
|
$212,000.00
|
$61,000.00
|
$181,000.00
|
$576,000.00
|
$26,000.00
|
$6,000.00
|
$3,000.00
|
$21,000.00
|
| Depreciation & Amortization |
$199,000.00
|
$201,000.00
|
$231,000.00
|
$235,000.00
|
$178,000.00
|
$7,000.00
|
$4,000.00
|
$1,999.54
|
$1,000.00
|
-$50,000.00
|
| EBITDA |
-$22.23 M |
-$21.49 M |
-$17.52 M |
-$28.41 M |
-$6.14 M |
-$5.55 M |
-$12.88 M |
-$7.04 M |
-$4.20 M |
-$5.43 M |
| EBITDA Ratio |
0
|
23.55
|
54.32
|
-27.96
|
-7.64
|
-7.73
|
-13.24
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
24.84
|
56.04
|
12.61
|
-7.16
|
-7.83
|
-13.59
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$42.25 M
|
-$43.52 M
|
$108,000.00
|
-$15.46 M
|
$1.48 M
|
$2.26 M
|
-$947,000.00
|
-$4.94 M
|
-$133,000.00
|
-$71,000.00
|
| Income Before Tax |
-$19.98 M
|
-$21.76 M
|
-$17.83 M
|
-$28.07 M
|
-$5.89 M
|
-$5.57 M
|
-$13.01 M
|
-$12.13 M
|
-$4.20 M
|
-$5.25 M
|
| Income Before Tax Ratio |
0
|
23.91
|
55.71
|
-28.07
|
-5.89
|
-5.57
|
-14.44
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
-$935,000.00
|
$637,000.00
|
-$15.67 M
|
$216,000.00
|
-$2.63 M
|
$26,000.00
|
$4.94 M
|
$133,000.00
|
$50,000.00
|
| Net Income |
-$19.88 M
|
-$20.83 M
|
-$18.46 M
|
-$12.41 M
|
-$6.11 M
|
-$5.20 M
|
-$12.27 M
|
-$12.13 M
|
-$4.20 M
|
-$5.25 M
|
| Net Income Ratio |
0
|
22.88
|
57.7
|
-12.41
|
-6.11
|
-5.2
|
-13.62
|
0
|
0
|
0
|
| EPS |
-0.0898 |
-1.13 |
-1.04 |
-0.72 |
-3.15 |
-0.27 |
-0.63 |
-0.62 |
-0.22 |
-234.38 |
| EPS Diluted |
-0.0898 |
-1.13 |
-1.04 |
-0.72 |
-3.15 |
-0.27 |
-0.63 |
-0.62 |
-0.22 |
-234.38 |
| Weighted Average Shares Out |
$221.33 M
|
$184.82 M
|
$178.00 M
|
$172.11 M
|
$1.94 M
|
$19.54 M
|
$19.54 M
|
$19.54 M
|
$19.54 M
|
$22,408.00
|
| Weighted Average Shares Out Diluted |
$221.33 M
|
$184.82 M
|
$178.00 M
|
$172.11 M
|
$1.94 M
|
$19.54 M
|
$19.54 M
|
$19.54 M
|
$19.54 M
|
$22,408.00
|
| Link |
|
|
|
|
|
|
|
|
|
|
